Bibliografía

Direct oral anticoagulants vs. vitamin K antagonist after percutaneous coronary interventions in patients with atrial fibrillation: a metanalysis of cardiac ischemic events.

Cordero A, Ferreiro JL, Bertomeu-González V, Rodríguez-Mañero M, Fácila L, Escribano D, Sanchez-Recalde A, Zuazola P, Ruiz-Nodar JM, González-Juanatey JR. J Cardiovasc Pharmacol. 2020 Dec 21;Publish Ahead of Print. doi: 10.1097/FJC.0000000000000938. Online ahead of print. PMID: 33351537

Clinical profile and prognosis in patients on oral anticoagulation before admission for COVID-19.

Rivera-Caravaca JM, Núñez-Gil IJ, Vivas D, Viana-Llamas MC, Uribarri A, Becerra-Muñoz VM, Trabattoni D, Fernández Rozas I, Feltes G, López-Pais J, El-Battrawy I, Macaya C, Fernandez-Ortiz A, Estrada V, Marín F; HOPE COVID-19 Investigators. Eur J Clin Invest. 2021 Jan;51(1):e13436. doi: 10.1111/eci.13436. Epub 2020 Nov 7. PMID: 33080051 Free PMC article.

[Recommendations on antithrombotic treatment during the COVID-19 pandemic. Position statement of the Working Group on Cardiovascular Thrombosis of the Spanish Society of Cardiology].

Vivas D, Roldán V, Esteve-Pastor MA, Roldán I, Tello-Montoliu A, Ruiz-Nodar JM, Cosín-Sales J, Gámez JM, Consuegra L, Ferreiro JL, Marín F; Revisores expertos. Rev Esp Cardiol. 2020 Sep;73(9):749-757. doi: 10.1016/j.recesp.2020.04.006. Epub 2020 Apr 22. PMID: 32327870 Free PMC article. Spanish.

One-year efficacy and safety of prasugrel and ticagrelor in patients with acute coronary syndromes: Results from a prospective and multicentre ACHILLES registry.

Ruiz-Nodar JM, Esteve-Pastor MA, Rivera-Caravaca JM, Sandín M, Lozano T, Vicente-Ibarra N, Orenes-Piñero E, Macías MJ, Pernías V, Carrillo L, Candela E, Veliz A, Tello-Montoliu A, Martínez Martínez JG, Marín F. Br J Clin Pharmacol. 2020 Jun;86(6):1052-1061. doi: 10.1111/bcp.14213. Epub 2020 Feb 3. PMID: 31912949

Pre-Treatment With Oral P2Y₁₂ Inhibitors in Non-ST-Segment Elevation Acute Coronary Syndromes: Does One Size Fit All?

Ferreiro JL. JACC Cardiovasc Interv. 2020 Apr 27;13(8):918-920. doi: 10.1016/j.jcin.2020.02.036. PMID: 32327088 No abstract available.

Prognostic impact of inappropriate doses of direct oral anticoagulants in clinical practice.

Ruiz Ortiz M, Esteve-Pastor MA, Roldán I, Muñiz J, Marín F, Anguita M; FANTASIIA study investigators. Rev Esp Cardiol (Engl Ed). 2020 Apr;73(4):329-330. doi: 10.1016/j.rec.2019.09.014. Epub 2019 Nov 27. PMID: 31786172 English, Spanish. No abstract available.

Ticagrelor in patients with myocardial infarction: is the treatment strategy crystal clear?

Lugo LM, Ferreiro JL. Eur Heart J Cardiovasc Pharmacother. 2019 Oct 1;5(4):207-209. doi: 10.1093/ehjcvp/pvz023. PMID: 31298282 No abstract available.

High and low on-treatment platelet reactivity to P2Y₁₂ inhibitors in a contemporary cohort of acute coronary syndrome patients undergoing percutaneous coronary intervention.

Ferreiro JL, Vivas D, De La Hera JM, Marcano AL, Lugo LM, Gómez-Polo JC, Silva I, Tello-Montoliu A, Marín F, Roldán I. Thromb Res. 2019 Mar;175:95-101. doi: 10.1016/j.thromres.2019.01.021. Epub 2019 Jan 31. PMID: 30738371

Bleeding Risk Prediction in Patients With Dual Antiplatelet Therapy Undergoing Coronary Artery Bypass Grafting Surgery Using a Rapid Point-of-Care Platelet Function Test.

Tello-Montoliu A, Albaladejo P, Hernández-Romero D, Taboada R, Albacete CL, Arribas JM, Jara R, Veliz A, López-García C, Cánovas S, Valdés M, Rivera-Caravaca JM, Marín F. Circ Cardiovasc Interv. 2018 Dec;11(12):e007264. doi: 10.1161/CIRCINTERVENTIONS.118.007264. PMID: 30525983 No abstract available.

Antithrombotic Therapy and Surgery: From Consensus to Clinical Practice. Response to Related Letters.

Vivas D, Ferreiro JL, Roldán I. Rev Esp Cardiol (Engl Ed). 2018 Oct;71(10):879. doi: 10.1016/j.rec.2018.05.032. Epub 2018 Aug 7. PMID: 30097395 English, Spanish. No abstract available.

Perioperative and Periprocedural Management of Antithrombotic Therapy: Consensus Document of SEC, SEDAR, SEACV, SECTCV, AEC, SECPRE, SEPD, SEGO, SEHH, SETH, SEMERGEN, SEMFYC, SEMG, SEMICYUC, SEMI, SEMES, SEPAR, SENEC, SEO, SEPA, SERVEI, SECOT and AEU.

Vivas D, Roldán I, Ferrandis R, Marín F, Roldán V, Tello-Montoliu A, Ruiz-Nodar JM, Gómez-Doblas JJ, Martín A, Llau JV, Ramos-Gallo MJ, Muñoz R, Arcelus JI, Leyva F, Alberca F, Oliva R, Gómez AM, Montero C, Arikan F, Ley L, Santos-Bueso E, Figuero E, Bujaldón A, Urbano J, Otero R, Hermida JF, Egocheaga I, Llisterri JL, Lobos JM, Serrano A, Madridano O, Ferreiro JL; Expert reviewers. Rev Esp Cardiol (Engl Ed). 2018 Jul;71(7):553-564. doi: 10.1016/j.rec.2018.01.029. Epub 2018 Jun 8. PMID: 29887180 English, Spanish.

Inappropriate doses of direct oral anticoagulants in real-world clinical practice: prevalence and associated factors. A subanalysis of the FANTASIIA Registry.

Ruiz Ortiz M, Muñiz J, Raña Míguez P, Roldán I, Marín F, Asunción Esteve-Pastor M, Cequier A, Martínez-Sellés M, Bertomeu V, Anguita M; FANTASIIA study investigators. Europace. 2018 Oct 1;20(10):1577-1583. doi: 10.1093/europace/eux316. PMID: 29186393

Comments on the 2017 ESC Focused Update on Dual Antiplatelet Therapy in Coronary Artery Disease.

SEC Working Group for the 2017 ESC Focused Update on Dual Antiplatelet Therapy in Coronary Artery Disease, Jiménez Navarro M, Avanzas P, Valencia F, Ballesteros S, Ruiz-Nodar JM, Ferreiro JL, Tello Montoliu A, Marín F; Expert Reviewers for the 2017 ESC Focused Update on Dual Antiplatelet Therapy in Coronary Artery Disease, Pérez de Prado A, Romero Moreno M, Bravo MS, Ruiz Ortiz M, Escobar C, Roldán I, Vivas Balcones D; SEC Guidelines Committee, San Román A, Alfonso F, Evangelista A, Ferreira-González I, Jiménez Navarro M, Marín F, Pérez de Isla L, Rodríguez Padial L, Sánchez Fernández PL, Sionis A, Vázquez García R. Rev Esp Cardiol (Engl Ed). 2018 Jan;71(1):6-12. doi: 10.1016/j.rec.2017.11.019. PMID: 29277237 English, Spanish. No abstract available.

Platelet reactivity over time in coronary artery disease patients treated with a bioabsorbable everolimus-eluting scaffold.

Tello-Montoliu A, Rivera J, Hernández-Romero D, Silvente A, Jover E, Quintana M, Orenes-Piñero E, Hurtado J, Ferreiro JL, Marín F, Valdés M. Platelets. 2016 Dec;27(8):777-783. doi: 10.1080/09537104.2016.1184750. Epub 2016 Jun 2. PMID: 27257022

Impact of Intravenous Lysine Acetylsalicylate Versus Oral Aspirin on Prasugrel-Inhibited Platelets: Results of a Prospective, Randomized, Crossover Study (the ECCLIPSE Trial).

Vivas D, Martín A, Bernardo E, Ortega-Pozzi MA, Tirado G, Fernández C, Vilacosta I, Núñez-Gil I, Macaya C, Fernández-Ortiz A. Circ Cardiovasc Interv. 2015 May;8(5):e002281. doi: 10.1161/CIRCINTERVENTIONS.114.002281. PMID: 25957056 Clinical Trial.

Impaired responsiveness to the platelet P2Y12 receptor antagonist clopidogrel in patients with type 2 diabetes and coronary artery disease.

Angiolillo DJ, Jakubowski JA, Ferreiro JL, Tello-Montoliu A, Rollini F, Franchi F, Ueno M, Darlington A, Desai B, Moser BA, Sugidachi A, Guzman LA, Bass TA. J Am Coll Cardiol. 2014 Sep 9;64(10):1005-14. doi: 10.1016/j.jacc.2014.06.1170. PMID: 25190236

Effect of an optimized treatment with insulin on platelet reactivity after discharge in patients with an acute coronary syndrome and hyperglycemia.

Vivas D, García-Rubira JC, Bernardo E, Angiolillo DJ, Martín P, Calle A, Núñez-Gil I, Macaya C, Fernández-Ortiz A. Rev Esp Cardiol (Engl Ed). 2014 Jan;67(1):22-7. doi: 10.1016/j.rec.2013.05.020. Epub 2013 Oct 3. PMID: 24774260 Clinical Trial.

Impact of smoking on long-term outcomes in patients with atherosclerotic vascular disease treated with aspirin or clopidogrel: insights from the CAPRIE trial (Clopidogrel Versus Aspirin in Patients at Risk of Ischemic Events).

Ferreiro JL, Bhatt DL, Ueno M, Bauer D, Angiolillo DJ. J Am Coll Cardiol. 2014 Mar 4;63(8):769-77. doi: 10.1016/j.jacc.2013.10.043. Epub 2013 Nov 13. PMID: 24239662 Clinical Trial.

Platelet function and genetic testing.

Angiolillo DJ, Ferreiro JL, Price MJ, Kirtane AJ, Stone GW. J Am Coll Cardiol. 2013 Oct 22;62(17 Suppl):S21-31. doi: 10.1016/j.jacc.2013.08.704. PMID: 24135660 Review. No abstract available.

Effects of intensive glucose control on platelet reactivity in patients with acute coronary syndromes. Results of the CHIPS Study ("Control de Hiperglucemia y Actividad Plaquetaria en Pacientes con Sindrome Coronario Agudo").

Vivas D, García-Rubira JC, Bernardo E, Angiolillo DJ, Martín P, Calle-Pascual A, Núñez-Gil I, Macaya C, Fernández-Ortiz A. Heart. 2011 May;97(10):803-9. doi: 10.1136/hrt.2010.219949. Epub 2011 Mar 4. PMID: 21378389 Clinical Trial.